Cancer Monoclonal Antibodies Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2020 – 2030

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Cancer Monoclonal Antibodies Market Year-on-Year Growth, 2021 – 2030 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook, and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Cancer Monoclonal Antibodies Market by Type: Market Size and Forecast, 2020 - 2030

4.1  Overview

4.2  Human mAb

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

4.3  Humanized mAb

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

4.4  Chimeric mAb

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

4.5  Murine mAb

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

Chapter 5        Global Cancer Monoclonal Antibodies Market by Application: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Cancer

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

5.3  Autoimmune Diseases

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

5.4  Others

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

Chapter 6    Global Cancer Monoclonal Antibodies Market by Distribution Channel: Market Size and Forecast, 2019 – 2028

6.1  Overview

6.2  Hospital Pharmacies

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

6.3  Hospital Pharmacies

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

6.4  Retail Pharmacies

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

6.5  Online Pharmacies

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.5.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

Chapter 7        Global Cancer Monoclonal Antibodies Market by Geography: Market Size and Forecast, 2020 – 2030 (%)

7.1  Overview

7.1.1   Global Cancer Monoclonal Antibodies Market Year-on-Year Growth, by region 2021 – 2030 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.3.2        By Type

7.2.3.3        By Application

7.2.3.4        By Distribution Channel

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.4.2        By Type

7.2.4.3        By Application

7.2.4.4        By Distribution Channel

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.5.2        By Type

7.2.5.3        By Application

7.2.5.4        By Distribution Channel

7.3    Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.3.2        By Type

7.3.3.3        By Application

7.3.3.4        By Distribution Channel

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.4.2        By Type

7.3.4.3        By Application

7.3.4.4        By Distribution Channel

7.3.5   France

7.3.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.5.2        By Type

7.3.5.3        By Application

7.3.5.4        By Distribution Channel

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.6.2        By Type

7.3.6.3        By Application

7.3.6.4        By Distribution Channel

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.7.2        By Type

7.3.7.3        By Application

7.3.7.4        By Distribution Channel

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.8.2        By Type

7.3.8.3        By Application

7.3.8.4        By Distribution Channel

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.3.2        By Type

7.4.3.3        By Application

7.4.3.4        By Distribution Channel

7.4.4   India

7.4.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.4.2        By Type

7.4.4.3        By Application

7.4.4.4        By Distribution Channel

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.5.2        By Type

7.4.5.3        By Application

7.4.5.4        By Distribution Channel

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.6.2        By Type

7.4.6.3        By Application

7.4.6.4        By Distribution Channel

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

7.5.3   South & Central America

7.5.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.5.3.2        By Type

7.5.3.3        By Application

7.5.3.4        By Distribution Channel

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.5.4.2        By Type

7.5.4.3        By Application

7.5.4.4        By Distribution Channel

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.5.5.2        By Type

7.5.5.3        By Application

7.5.5.4        By Distribution Channel

Chapter 8        Company Profiles

8.1  Eli Lilly and Company

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  F. Hoffmann-La Roche Ltd

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  Amgen

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  Bristol Myers Squibb Company

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  Genmab AS

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  GlaxoSmithKline

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  Johnson & Johnson

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  Novartis AG

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4     Financials

8.8.5     Recent Developments

8.9  Merck & Co.      

8.9.1     Company Overview

8.9.2     Product Portfolio

8.9.3     Business Strategies

8.9.4     Financials

8.9.5     Recent Developments

8.10   Spectrum Pharmaceuticals

8.10.1   Company Overview

8.10.2   Product Portfolio

8.10.3   Business Strategies

8.10.4   Financials

8.10.5   Recent Developments

8.11 Others

8.11.1   Company Overview

8.11.2   Product Portfolio

8.11.3   Business Strategies

8.11.4   Financials

8.11.5   Recent Developments